Education
About Us
Working with TipRanks
Follow Us
Vivimed Labs Limited (IN:VIVIMEDLAB)
:VIVIMEDLAB
Total Valuation
Vivimed Labs Limited has a market cap or net worth of $406.28M. The enterprise value is $4.18B.
Market Cap$406.28M
Enterprise Value$4.18B
Share Statistics
Vivimed Labs Limited has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Vivimed Labs Limited’s return on equity (ROE) is -8.33 and return on invested capital (ROIC) is -28.96%.
Return on Equity (ROE)-8.33
Return on Assets (ROA)-0.33
Return on Invested Capital (ROIC)-28.96%
Return on Capital Employed (ROCE)-0.22
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.19
Inventory Turnover3.51
Valuation Ratios
The current PE Ratio of Vivimed Labs Limited is -0.17. Vivimed Labs Limited’s PEG ratio is -0.18.
PE Ratio-0.17
PS Ratio―
PB Ratio1.04
Price to Fair Value1.39
Price to FCF1.35
Price to Operating Cash Flow2.97
PEG Ratio-0.18
Income Statement
In the last 12 months, Vivimed Labs Limited had revenue of 1.87B and earned -3.29B in profits. Earnings per share was -39.62.
Revenue1.87B
Gross Profit-928.65M
Operating Income-1.22B
Pretax Income-3.31B
Net Income-3.29B
EBITDA-1.86B
Earnings Per Share (EPS)-39.62
Cash Flow
In the last 12 months, operating cash flow was 2.20B and capital expenditures 0.00, giving a free cash flow of 2.20B billion.
Operating Cash Flow2.20B
Free Cash Flow2.20B
Free Cash Flow per Share―
Dividends & Yields
Vivimed Labs Limited pays an annual dividend of $0.4, resulting in a dividend yield of ―
Dividend Per Share$0.4
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Vivimed Labs Limited upcoming earnings date is Aug 8, 2025, TBA Not Confirmed.
Last Earnings DateFeb 14, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend DateSep 19, 2018
Financial Position
Vivimed Labs Limited as a current ratio of 0.78, with Debt / Equity ratio of 966.53%
Current Ratio0.78
Quick Ratio0.60
Debt to Market Cap6.92
Net Debt to EBITDA-2.03
Interest Coverage Ratio-3.36
Taxes
In the past 12 months, Vivimed Labs Limited has paid -21.17M in taxes.
Income Tax-21.17M
Effective Tax Rate<0.01
Enterprise Valuation
Vivimed Labs Limited EV to EBITDA ratio is -2.32, with an EV/FCF ratio of 14.23.
EV to Sales2.31
EV to EBITDA-2.32
EV to Free Cash Flow14.23
EV to Operating Cash Flow31.28
Balance Sheet
Vivimed Labs Limited has $22.77M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -$22.77M billion.
Cash & Marketable Securities$22.77M
Total Debt₹0.00
Net Cash-$22.77M
Net Cash Per Share―
Tangible Book Value Per Share-$14.26
Margins
Gross margin is -49.63%, with operating margin of -65.11%, and net profit margin of -175.59%.
Gross Margin-49.63%
Operating Margin-65.11%
Pretax Margin-176.72%
Net Profit Margin-175.59%
EBITDA Margin-99.37%
EBIT Margin-109.59%
Analyst Forecast
The average price target for Vivimed Labs Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―